Akers Biosciences (AKER) Stock Price & Overview

NASDAQ:AKER

Current stock price

2.47
-0.26 (-9.52%)
At close:
2.43
-0.04 (-1.62%)
After Hours:

The current stock price of AKER is 2.47 null. Today AKER is down by -9.52%. In the past month the price decreased by -29.83%. In the past year, price decreased by -27.78%.

AKER Key Statistics

52-Week Range1.65 - 6.97
Current AKER stock price positioned within its 52-week range.
1-Month Range2.4044 - 4.09
Current AKER stock price positioned within its 1-month range.
Market Cap
41.133M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-4.25
Dividend Yield
N/A

AKER Stock Performance

Today
-9.52%
1 Week
-23.05%
1 Month
-29.83%
3 Months
-6.79%
Longer-term
6 Months +8.81%
1 Year -27.78%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

AKER Stock Chart

Akers Biosciences / AKER Daily stock chart

AKER Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to AKER. When comparing the yearly performance of all stocks, AKER is a bad performer in the overall market: 94.84% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
AKER Full Technical Analysis Report

AKER Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AKER. No worries on liquidiy or solvency for AKER as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AKER Full Fundamental Analysis Report

AKER Earnings

Next Earnings DateFeb 28, 2022
Last Earnings DateN/A
AKER Earnings History

AKER Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
AKER Forecast & Estimates

AKER Financial Highlights

Over the last trailing twelve months AKER reported a non-GAAP Earnings per Share(EPS) of -4.25. The EPS increased by 17.32% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-17.58M
Industry RankSector Rank
PM (TTM) N/A
ROA -47.72%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%77.38%
Sales Q2Q%-100%
EPS 1Y (TTM)17.32%
Revenue 1Y (TTM)N/A
AKER financials

AKER Ownership

Ownership
Inst Owners6.24%
Shares16.65M
Float16.65M
Ins Owners6.7%
Short Float %N/A
Short RatioN/A
AKER Ownership

About AKER

Company Profile

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.

Company Info

Akers Biosciences

201 GROVE RD

THOROFARE NJ 08086

CEO: Christopher C. Schreiber

Phone: 856-848-8698

Akers Biosciences / AKER FAQ

What does Akers Biosciences do?

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.


What is the stock price of Akers Biosciences today?

The current stock price of AKER is 2.47 null. The price decreased by -9.52% in the last trading session.


Does Akers Biosciences pay dividends?

AKER does not pay a dividend.


What is the ChartMill technical and fundamental rating of AKER stock?

AKER has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in Akers Biosciences be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AKER.